Amphastar Pharmaceuticals
AMPH
AMPH
207 hedge funds and large institutions have $839M invested in Amphastar Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 80 increasing their positions, 81 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
21% less capital invested
Capital invested by funds: $1.06B → $839M (-$223M)
40% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 35
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
207
Holding in Top 10
–
Calls
$2.77M
Puts
$935K
Top Buyers
| 1 | +$18.2M | |
| 2 | +$4.71M | |
| 3 | +$3.76M | |
| 4 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$2.35M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$2.33M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$7.69M | |
| 3 | -$6.7M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$5.22M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$4.9M |